13 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
GLP-1 receptor agonists ... Improved outcomes in CKD ... medications #table #comparison ... #management #endocrinology ... #dm2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
in Diabetes Management ... - PPAR gamma agonist ... ) 3 CARB ABSORPTION ... #Management #pharmacology ... #DM2 #DMII #Classification
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... agents There are ... #pharmacology #pharmacotherapy ... #management #medications ... #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
GLP-1 receptor agonist ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... There is an ORAL ... #Pharmacology #Dosing ... #Diabetes #DM2 ... #Endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... of an ACEi or ARB ... ml/min per 1.73 m2 ... evidence-based pharmacologic ... #Diabetes #CKD #
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Glucagon-like peptide 1; normally ... Summary #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... peptidase 4), which normally ... GLP-I receptor agonist ... #Summary #DM2 # ... diabetes #endocrinology
Impact and Challenges With Vitamin D to Treat Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
Ergocalciferol (D2 ... Biologically active VDR agonist ... SHPT - Reduces abnormal ... #Nephrology #Management ... #Pharmacology #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... GLP1 agonists are ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology